Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

Middle East Respiratory Syndrome (MERS) is a highly lethal pulmonary infection caused by a previously unidentified coronavirus (CoV), likely transmitted to humans by infected camels. There is no licensed vaccine or antiviral for MERS, therefore new prophylactic and therapeutic strategies to combat h...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Proc Natl Acad Sci U S A
Huvudupphovsmän: Corti, Davide, Zhao, Jincun, Pedotti, Mattia, Simonelli, Luca, Agnihothram, Sudhakar, Fett, Craig, Fernandez-Rodriguez, Blanca, Foglierini, Mathilde, Agatic, Gloria, Vanzetta, Fabrizia, Gopal, Robin, Langrish, Christopher J., Barrett, Nicholas A, Sallusto, Federica, Baric, Ralph S., Varani, Luca, Zambon, Maria, Perlman, Stanley, Lanzavecchia, Antonio
Materialtyp: Artigo
Språk:Inglês
Publicerad: National Academy of Sciences 2015
Ämnen:
Biological Sciences
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4547275/
https://ncbi.nlm.nih.gov/pubmed/26216974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1510199112
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk